Skip to main content

Advertisement

Table 1 Characteristics of HIV-infected patients diagnosed with Kaposi’s sarcoma between 2009–2012 in Kenya, Uganda, Nigeria, Cameroon and Malawi

From: Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi’s sarcoma in five countries across sub-Saharan Africa

  AMPATH Kenya (n = 677) ISS Uganda (n = 172) UATH and NHA Nigeria (n = 57) Yaounde and Limbe Cameroon (n = 67) Lighthouse Malawi (n = 355) Total (n = 1328)
Male sex, %a 60 % 60 % 49 % 49 % 72 % 60 %
Age, yearsa 35 (30–42)b 33 (28–40) 36 (30–41) 35 (30–41) 34 (30–40) 35 (30–41)
CD4+ T cell count/μlc
  ≤ 50 25 % 24 % 33 % 17 % 11 % 23 %
 51-200 32 % 31 % 17 % 50 % 46 % 35 %
 201-350 21 % 28 % 39 % 21 % 30 % 24 %
  > 350 21 % 16 % 11 % 12 % 13 % 18 %
  1. AMPATH denotes Academic Model Providing Access to Healthcare, ISS denotes Immune Suppression Syndrome Clinic, UATH denotes University of Abuja Teaching Hospital, NHA denotes National Hospital of Abuja
  2. atwo missing values for sex, four missing values for age
  3. bmedian (interquartile range)
  4. cCD4+ T cell count proximal to KS diagnosis, defined as closest CD4 count to date of KS diagnosis within the period 180 days prior to diagnosis to 14 days after diagnosis. CD4 data is missing in 33 % of patients. Data presented represent observed (not imputed) values only